By Eli Hughes–
UPS has pledged a $100,000 donation to the University of Louisville to fund research into a potential COVID-19 treatment.
The UPS donation will help fund the trials and pay for the test materials needed for COVID-19 research.
The funding will go to support research like Paula Bates’, which has shown promise in inhibiting COVID-19. Wanting to apply her prior research to the current COVID-19 outbreak, Bates partnered with Kenneth Palmer, the director of U of L’s Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases.
Bates’ treatment involves an aptamer, a piece of synthetic DNA, that she discovered along with John Trent and Don Miller.